Format

Send to

Choose Destination
Mol Ther. 2019 Nov 6;27(11):1869-1871. doi: 10.1016/j.ymthe.2019.09.021. Epub 2019 Oct 1.

CARdiac Immunotherapy: T Cells Engineered to Treat the Fibrotic Heart.

Author information

1
Department of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
2
Department of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Howard Hughes Medical Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Electronic address: jeff.molkentin@cchmc.org.
PMID:
31585799
PMCID:
PMC6838878
[Available on 2020-11-06]
DOI:
10.1016/j.ymthe.2019.09.021

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center